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In this data, non-pregnant women during the menstrual cycle,
women with normal intrauterine pregnancy (IUP), and women
with tubal ectopic pregnancy (EP) after informed consent were
included. The serum levels of 17β-estradiol, progesterone, testos-
terone, beta-human chorionic gonadotropin, interleukin (IL)-1β,
IL-4, IL-6, IL-7, IL-8, IL-10, tumor necrosis factor α (TNFα), and
interferon-γ (IFN-γ), epidermal growth factor, the Chlamydia (C.)
trachomatis IgG and HSP60 were analyzed. Receiver operating
characteristic analysis was used to assess the diagnostic dis-
crimination of tubal EP and gestational age-matched IUP. Our data
show that C. trachomatis infection is associated with IL-8 levels,
which had excellent discriminative validity in positively identify-
ing tubal EP (concomitant with C. trachomatis infection) from IUP
and non-pregnant conditions regardless of C. trachomatis infection.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
ax: þ46 31 7863512.
hao).
siologi/endo/staff/ruijin_shao/ (R. Shao).
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Dubject area Biomedicine
ore speciﬁc sub-
ject areaEctopic pregnancy in humans, clinical biomarkersype of data Tables and ﬁgure
ow data was
acquiredCompetitive RIA, human cytokine magnetic bead array and ELISA kitsata format Analyzed and graphed
xperimental
factorsA total of 225 blood samples were obtained (139 in the non-pregnant
menstrual cycle group, 50 in the early intrauterine pregnancy (IUP) group,
and 36 in the tubal EP group). Clinical information on the patients was col-
lected and entered into a dedicated database. The serum levels of 17β-
estradiol, progesterone, testosterone, beta-human chorionic gonadotropin
were measured by competitive RIA using direct-coated tube technology. The
serum levels of IL-1β, IL-4, IL-6, IL-7, IL-8, IL-10, tumor necrosis factor α
(TNFα), and interferon-γ (IFN-γ) cytokines were quantiﬁed by high sensi-
tivity human cytokine magnetic bead array.xperimental
features1. Epidermal growth factor (EGF), a marker of trophoblast invasion and pla-
cental development, was measured.
2. The C. trachomatis IgG and HSP60 human ELISA kits were used for screening
and diagnosis of C. trachomatis infection.
3. Receiver operating characteristic (ROC) curves were used to assess the
speciﬁcity and sensitivity of the cytokine levels in response to C. trachomatis
infection for discriminating tubal EP from IUP and non-pregnant conditions.ata source
locationShanghai, Chinaata accessibility Data are available with this articleDValue of the data1. The data indicate that using a combination of serum IL-8 and steroid hormone levels can possibly
differentiate a certain group of women with tubal EP from those with normal early IUP.
2. The data are useful for dissecting the molecular mechanism of different cytokines in the Fallopian
tube after C. trachomatis infection and for how they participate in the development of tubal EP.
3. The data may provide a new diagnostic opportunity for tubal EP in women with C. trachomatis
infection.1. Data1. The demographics and laboratory characteristics of the normal menstrual cycle women and those
with IUP and EP are shown in Table 1. The rates of C. trachomatis infection in the womenwith tubal
EP, IUP, and no pregnancy were 86.11%, 60.00%, and 55.40%, respectively (Table 2).
2. Although there was no signiﬁcant difference in IL-8 levels between IUP and non-pregnancy, IL-8
levels were signiﬁcantly higher in C. trachomatis-positive women with tubal EP than in women
with IUP and in non-pregnant women regardless of C. trachomatis infection status (Table 2). The
diagnostic accuracy of the various parameters (E2, P4, T levels and the E2:P4, E2:EGF, E2:IL-8, P4:
Table 1
Patient characteristics and hormonal proﬁles.
n Age GA E2 P4 E2 / P4 T β-hCG Chlamydia IgG posi-
tive (%)(years) (days) (pg/mL) (ng/mL) (ng/mL) (mIU/mL)
Menstrual cycle phase 55.40%
Proliferative 44 25.9870.58 – 37.1674.22 0.9470.12nnn 0.06107 0.0096 0.2470.03 –
Early secretive 25 24.4870.48 – 41.1777.49 2.9670.65 0.041670.0152 0.3270.06 –
Mid secretive 37 24.7070.34 – 43.5977.16 5.1970.72 0.051370.0298 0.2670.05 –
Late secretive 33 24.0970.36 – 34.0178.37 2.8370.66 0.047970.0160 0.3970.07 –
Early IUP 50 27.0270.67 51.3070.81 227.20713.73nnn 10.4770.50nnn 0.023470.0015 0.5170.05nn 16765.217582.99 60.00%
EP 36 27.7270.67 47.9472.26 61.037 13.13a 6.0070.80a 0.015070.0035 0.4470.05 3098.1971002.64a 86.11%
GA, gestational age; IUP, intrauterine pregnancy; EP, ectopic pregnancy.
Data are presented as mean 7SEM. Statistical analysis was performed using SPSS version 19.0 for Windows (SPSS Inc., Chicago, IL).
A nonparametric, unpaired test (Kruskal–Wallis test) followed by Dunnett's post hoc test was used for comparison of continuous variables.
nn po0.01.
nnn po0.001 vs. the mid secretive phase of the endometrial cycle.
a po0.001 vs. the early IUP.
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Table 2
Patient cytokine, IFNγ, TNFα and EGF levels.
Menstrual cycle phase Early IUP EP
Proliferative Early secretive Mid secretive Late secretive
C ( þ) C () C (þ) C () C (þ) C () C (þ) C () C (þ) C () C (þ) C ()
(n¼32) (n¼12) (n¼19) (n¼6) (n¼16) (n¼21) (n¼10) (n¼22) (n¼30) (n¼20) (n¼31) (n¼5)
IL-1β 12.1277.88 0.6270.25 3.9972.21 1.0571.05 6.6472.59 1.0570.60 1.4470.57 0.7070.34 0.9170.44 1.7370.87 5.2972.08 6.2572.79
IL-4 29.98717.89 4.3971.76 21.7178.26 U.D. 9.8276.07 18.0679.26 1.3871.38 19.50710.66 8.4175.37 2.1371.05 8.4173.01 38.98719.48
IL-6 4.6471.64 1.9771.01 5.5873.36 1.7370.70 6.6673.95 4.1371.19 1.5970.61 3.6471.46 9.7275.86 2.8571.20 4.3971.20 8.6670.91
IL-7 7.8871.19 10.7273.55 4.9670.77 3.9871.62 14.3079.43 8.3173.74 5.0771.96 3.9770.72 15.32712.00 5.4371.48 5.0670.88 11.0274.52
IL-8 18.1473.93 15.1374.54 21.0274.11 30.05713.57 19.3773.41 37.64713.96 15.4973.77 32.69710.43 6.0371.12 7.0671.57 309.057163.91nn,a 53.76730.73
IL-10 40.00730.35 80.72768.14 10.9073.42 11.7177.31 49.42740.10 9.6672.14 6.7072.80 14.7173.82 40.25730.91 9.3673.89 15.9276.95 25.79713.21
IFNγ 13.7673.01 37.29732.71 43.88733.25 7.3672.88 12.6173.36 23.89711.28 5.7571.69 18.4179.40 6.6474.06 4.7772.32 3.9470.86 22.83713.65
TNFα 13.8074.28 9.7974.26 8.8973.04 4.3370.72 8.4272.02 5.8670.79 7.1571.31 4.9070.81 3.8270.96 3.1970.72 6.8971.82 10.7772.65
EGF 288.29723.59 280.47733.24 343.31737.18 367.91764.03 305.10745.50 299.69738.64 393.10748.15 329.70728.29 557.49748.35nnn 558.87753.45 553.60771.60nnn 396.22760.06
IUP, intrauterine pregnancy; EP, ectopic pregnancy; C (þ), Chlamydia trachomatis IgG positive; C (), Chlamydia trachomatis IgG negative. U.D., under the detection.
The units of all cytokines and factors are pg/mL.
Data are presented as mean7SEM. Statistical analysis was performed using SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL).
A nonparametric, unpaired test (Kruskal–Wallis test) followed by Dunnett's post hoc test was used for comparison of continuous variables.
nn po0.01.
nnn po0.001 vs. mid secretive phase of menstrual cycle C (þ).
a po0.001 vs. the early IUP C(þ).
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Reference Line    
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Source of the Curve
Fig. 1. (A) E2, P4, T levels and the E2:P4 ratio as diagnostic tests for women with tubal EP were assessed by the receiver
operating curve (ROC) test. ROC analysis was performed with SPSS version 16.0 for Windows, and statistical signiﬁcance (P-
value) is indicated. The area under the curve was 0.97 (95% CI: 0.94–1.00) for E2, 0.92 (95% CI: 0.88–0.97) for P4, 0.72 (95% CI:
0.62–0.83) for T, and 0.56 (95% CI: 0.49–0.65) for the E2:P4 ratio. (B) The E2:EGF and E2:IL-8 ratio as diagnostic tests for women
with tubal EP were assessed by the ROC test. The area under the curve was 0.88 (95% CI: 0.81–0.96) for the E2:EGF ratio, and
0.97 (95% CI: 0.95–1.00) for the E2:IL-8. (C) The P4:EGF and P4:IL-8 ratio as diagnostic tests for women with tubal EP were
assessed by the ROC test. The area under the curve was 0.84 (95% CI: 0.76–0.93) for the P4:EGF ratio, and 0.97 (95% CI: 0.93–
1.00) for the P4:IL-8 ratio.
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R. Shao et al. / Data in Brief 6 (2016) 135–142140EGF, and P4:IL-8 ratio) in the tubal EP and early IUP groups was evaluated by ROC analysis (Fig. 1).
The ROC analysis showed that the IL-8 level had excellent discriminative validity in positively
identifying tubal EP (concomitant with C. trachomatis infection) from IUP and non-pregnant
conditions regardless of C. trachomatis infection (Fig. 1).
3. An increase in IL-1β levels and a decrease in IL-10 levels were observed in C. trachomatis-positive
women with tubal EP compared to C. trachomatis-positive women with IUP and C. trachomatis-
positive non-pregnant women (Table 2).
4. There were no signiﬁcant differences in IL-4, IL-6, IL-7, IL-8, TNFα, or IFN-γ levels among C.
trachomatis-positive or negative women under pregnant and non-pregnant conditions (Table 2).
5. We also found that individual measurements of serum EGF levels were strongly related to early
pregnancy outcomes for women with tubal EP and IUP (Table 2).2. Experimental design, materials and methods
2.1. Ethics statement
This study was approved by the Ethics Committees of the Obstetrics and Gynecology Hospital and
Shanghai Medical College, Fudan University, China. All participants provided informed consent.
2.2. Experimental design and sample collection
All participants underwent clinical examination at the Obstetrics and Gynecology Hospital of
Fudan University, Shanghai, China. Clinical work-up included menstrual history as well as current
cycle length and menstrual regularity. Exclusion criteria included use of estrogen- or progestin-
containing medication within three months of the study, past EP, any gynecological pathology (e.g.,
endometriosis, ﬁbroids, or any operation to the gynecological organs), infection, and smoking. All the
patients whose pregnancies resulted from assisted reproductive technologies were also excluded
from the study. Blood samples were collected into Sarstedt evacuated tubes without anticoagulant. All
blood samples were centrifuged at 1000 g for 15 min, and the serum was stored at –80° C until
batch analyses. The present study included non-pregnant and pregnant women (total n¼225) who
were subdivided into the following groups:
1. Group 1. The different stages of the menstrual cycle in non-pregnant women (n¼139) were
studied. Blood samples were collected at the scheduled visits during their menstrual cycle.
Menstrual cycle day was established using the criteria reported by Noyes et al. [1]. Sample datingTable 3
The intra-assay and inter-assay % CV for the human cytokine magnetic bead kit and angiogenesis/growth factor magnetic bead
panel 1 kit.
Analyze Intra-assay % CV Inter-assay % CV
IL-1β 9.3 9.6
IL-4 10.8 15.6
IL-6 11.9 10.3
IL-7 10.9 15.6
IL-8 3.0 7.1
IL-10 10.0 15.2
IFNγ 10.6 9.5
TNFα 10.6 9.8
EGF 3.2 6.8
Chlamydia IgG 3.7 2.8
Chlamydia IgG was detected by Chlamydia trachomatis IgG human ELISA kit.
Positive: 411 NTU; Negative: o11 NTU.
NTU: Abcam units.
R. Shao et al. / Data in Brief 6 (2016) 135–142 141characterized the samples as coming from the proliferative (days 1–14 of the cycle), early secretive
(days 15–18), mid-secretive (days 19–23), and late secretive (days 24–28) phases of the menstrual
cycle. Regular menstrual cycles were deﬁned as an average cycle length of 26–30 days, with no
more variation than73 days from the average. Transabdominal ultrasonography was also
performed to assess ovarian volume and uterine thickness.
2. Group 2. This group comprised healthy IUP women (n¼50). Blood samples were collected at the
scheduled visits during their IUP, and on days 1–3 after spontaneous labor and vaginal delivery. The
diagnosis of a normal IUP was made upon the observation of an intrauterine gestational sac or a
live embryo on the transvaginal or transabdominal ultrasound scan. Only women with normally
progressing pregnancies were studied during their visits to the prenatal clinic during the early
stage of their IUP.
3. Group 3. In this group, women with tubal EP (n¼36) were studied before and after tubal surgery
and matched to a subgroup of women with early IUP. A full medical history was documented, and
clinical examination was carried out by the attending physician. Transvaginal ultrasonography was
performed and the serum β-hCG levels were analyzed in patients at the time of their ﬁrst clinical
presentation. Blood samples were collected from patients at the time of surgery or 2–3 days after
surgery. None of the women undergoing surgical management of EP presented with acute
hemodynamic shock. Women with EP were diagnosed during laparoscopy and on histological
examination of the surgical specimens.
2.3. Main outcome measures
All sera were stored at –80 °C before performing the assays, and aliquots that had not been pre-
viously thawed were used in the present study. Samples were tested in duplicate and analyzed
individually. Radioimmunoassays (RIA) were performed at Beijing Free Co. (China), and enzyme-
linked immunoassays (ELISA) were performed at the Department of Integrative Medicine and Neu-
robiology, Shanghai Medical College, Fudan University (China). The averages of the duplicate readings
for each standard, control, and individual samples were used for the analyses.
1. 17β-estradiol (E2), progesterone (P4), testosterone (T), and β-hCG assays: Serum E2 (with an assay
sensitivity less than 5.0 pg/mL, an intra-assay coefﬁcient of variation (CV) of 10.0%, and an
interassay CV of 15.2%), P4 (with an assay sensitivity less than 5.0 ng/mL, an intra-assay CV of
5.0%, and an interassay CV of 10.0%), T (with an assay sensitivity less than 0.1 ng/mL, an intra-assay
CV of 8.0%, and an interassay CV of 15.0%), and β-hCG (with an assay sensitivity less than
10.0 mIU/mL, an intra-assay CV of 5.0%, and an interassay CV of 10.0%) levels were measured by
competitive RIA (125I-Kit, Beijing Free Co.) using direct-coated tube technology. E2, P4, T, and β-hCG
were labeled with 125I as the tracer, and known quantities of unlabeled E2, P4, T, and β-hCG were
used to construct standard curves. The concentrations used for the standard curves were
0–4000 pg/mL for E2, 0–100 ng/mL for P4, 0–10 ng/mL for T, and 0–1600 mIU/mL for β-hCG.
2. Human cytokine magnetic bead array: The levels of cytokines and growth factors were detected by
BioPlex instrument (Bio-rad Hercules, CA) using the high sensitivity human cytokine magnetic
bead kit (HSCYTMAG-60SK) and angiogenesis/growth factor magnetic bead panel 1 kit (HAGP1-
MAG-12K) kits (Merck Millipore Corporation, Billerica, MA) according to the manufacture’s
instruction. The intra-assay and inter-assay % CV were indicated in Table 3.
2.4. Statistical analysis
Numerical, grouped results are expressed as the mean7SEM. In all analyses, a P value less than
0.05 was considered statistically signiﬁcant. Statistical analysis was performed using SPSS version
16.0 for Windows (SPSS Inc., Chicago, IL). Comparison among the various groups was performed using
nonparametric tests (Kruskal–Wallis followed by multiple comparison procedures according to
Dunn’s method) because our variables did not have a normal distribution. Correlation between
variables was performed using Spearman’s analysis. The speciﬁcity and sensitivity of the various
assays as diagnostic tests were assessed using receiver operating characteristic (ROC) curve analysis
R. Shao et al. / Data in Brief 6 (2016) 135–142142[2]. As opposed to accuracy, sensitivity and speciﬁcity are not dependent on the prevalence of the
disease in the sample. Thus, ROC curve analysis provides a description of disease detectability that is
independent of both disease prevalence and decision threshold effects. For ROC analysis, women with
EP were considered affected, and IUP as unaffected. ROC curves were constructed by plotting the
sensitivity (true-positive) on the ordinate as a function of the complement of speciﬁcity (false-
positive) for all possible cut-off values of the diagnostic test [3]. Greater deviation toward the left
upper corner of the curve indicates better detection of tubal EP.Competing interests
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